Osaic Holdings’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.2K | Buy |
1,624
+576
| +55% | +$10.4K | ﹤0.01% | 5070 |
|
|
2025
Q1 | $14.3K | Sell |
1,048
-545
| -34% | -$7.41K | ﹤0.01% | 5540 |
|
|
2024
Q4 | $32.5K | Buy |
1,593
+296
| +23% | +$6.03K | ﹤0.01% | 4987 |
|
|
2024
Q3 | $37.8K | Buy |
1,297
+447
| +53% | +$13K | ﹤0.01% | 4917 |
|
|
2024
Q2 | $19.7K | Buy |
850
+211
| +33% | +$4.9K | ﹤0.01% | 5310 |
|
|
2024
Q1 | $13.1K | Sell |
639
-873
| -58% | -$17.9K | ﹤0.01% | 5546 |
|
|
2023
Q4 | $32.4K | Sell |
1,512
-3,165
| -68% | -$67.8K | ﹤0.01% | 5178 |
|
|
2023
Q3 | $96.5K | Buy |
4,677
+2,478
| +113% | +$51.1K | ﹤0.01% | 4532 |
|
|
2023
Q2 | $64.9K | Sell |
2,199
-119
| -5% | -$3.51K | ﹤0.01% | 4759 |
|
|
2023
Q1 | $53.4K | Buy |
2,318
+98
| +4% | +$2.26K | ﹤0.01% | 4896 |
|
|
2022
Q4 | $61.6K | Sell |
2,220
-610
| -22% | -$16.9K | ﹤0.01% | 4777 |
|
|
2022
Q3 | $87K | Buy |
2,830
+566
| +25% | +$17.4K | ﹤0.01% | 4481 |
|
|
2022
Q2 | $66K | Sell |
2,264
-53
| -2% | -$1.55K | ﹤0.01% | 4730 |
|
|
2022
Q1 | $75K | Buy |
2,317
+214
| +10% | +$6.93K | ﹤0.01% | 4785 |
|
|
2021
Q4 | $95K | Buy |
2,103
+542
| +35% | +$24.5K | ﹤0.01% | 4633 |
|
|
2021
Q3 | $80K | Buy |
1,561
+863
| +124% | +$44.2K | ﹤0.01% | 4721 |
|
|
2021
Q2 | $54K | Sell |
698
-135
| -16% | -$10.4K | ﹤0.01% | 4976 |
|
|
2021
Q1 | $48K | Sell |
833
-689
| -45% | -$39.7K | ﹤0.01% | 4897 |
|
|
2020
Q4 | $128K | Buy |
1,522
+772
| +103% | +$64.9K | ﹤0.01% | 3856 |
|
|
2020
Q3 | $27K | Sell |
750
-200
| -21% | -$7.2K | ﹤0.01% | 4709 |
|
|
2020
Q2 | $23K | Sell |
950
-243
| -20% | -$5.88K | ﹤0.01% | 4680 |
|
|
2020
Q1 | $21K | Buy |
+1,193
| New | +$21K | ﹤0.01% | 4562 |
|